DK139101B - Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. - Google Patents
Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.Info
- Publication number
- DK139101B DK139101B DK358875AA DK358875A DK139101B DK 139101 B DK139101 B DK 139101B DK 358875A A DK358875A A DK 358875AA DK 358875 A DK358875 A DK 358875A DK 139101 B DK139101 B DK 139101B
- Authority
- DK
- Denmark
- Prior art keywords
- 14beta
- 5beta
- 17beta
- 3beta
- pyridazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1085574A CH621803A5 (es) | 1974-08-08 | 1974-08-08 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK358875A DK358875A (es) | 1976-02-09 |
DK139101B true DK139101B (da) | 1978-12-18 |
DK139101C DK139101C (es) | 1979-05-21 |
Family
ID=4367535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK358875AA DK139101B (da) | 1974-08-08 | 1975-08-07 | Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4000125A (es) |
JP (1) | JPS5141372A (es) |
AR (1) | AR217617A1 (es) |
BE (1) | BE832271A (es) |
CA (1) | CA1049499A (es) |
CH (1) | CH621803A5 (es) |
DE (1) | DE2534981A1 (es) |
DK (1) | DK139101B (es) |
ES (1) | ES440110A1 (es) |
FR (1) | FR2281124A1 (es) |
GB (1) | GB1484655A (es) |
SE (1) | SE418401B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1144136B (it) * | 1980-03-05 | 1986-10-29 | Zenyaku Kogyo Kk | Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione |
US5373095A (en) * | 1985-10-18 | 1994-12-13 | The Upjohn Company | Steroid compounds |
IT1262931B (it) * | 1992-01-16 | 1996-07-22 | Zambon Spa | Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare |
DE4227616C2 (de) * | 1992-08-20 | 1995-04-13 | Sigma Tau Ind Farmaceuti | 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen |
DK2206719T3 (en) * | 2005-03-02 | 2015-01-26 | Univ Maryland | A pharmaceutical composition comprising 3-BETA-HYDROXY-17- (1-H-benzimidazol-1-yl) androsta-5, 16-DIEN |
WO2009114658A2 (en) * | 2008-03-12 | 2009-09-17 | University Of Maryland, Baltimore | Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer |
US20100048524A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
GB2470700B (en) | 2008-03-25 | 2012-08-08 | Univ Maryland | C-17 heteroaryl steroidal CYP17 inhibitors |
US8785423B2 (en) * | 2008-04-14 | 2014-07-22 | University Of Maryland, Baltimore | Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
JP2012516900A (ja) | 2009-02-05 | 2012-07-26 | トーカイ ファーマシューティカルズ,インク. | ステロイド性cyp17阻害剤/抗アンドロゲン剤の新しいプロドラッグ |
GB2479693B (en) | 2009-02-05 | 2014-04-09 | Tokai Pharmaceuticals Inc | Steroidal CYP17 inhibitors and their use in the treatment of cancer and prostate hyperplasia |
AU2010279398A1 (en) * | 2009-08-07 | 2012-03-08 | Tokai Pharmaceuticals, Inc. | Treatment of prostate cancer |
WO2014153215A1 (en) | 2013-03-14 | 2014-09-25 | University Of Maryland,Baltimore Office Of Technology Transfer | Androgen receptor down-regulating agents and uses thereof |
JP2016528252A (ja) | 2013-08-12 | 2016-09-15 | トーカイ ファーマシューティカルズ, インコーポレイテッド | アンドロゲン標的治療を使用する新生物障害の処置のためのバイオマーカー |
EP3313858B1 (en) * | 2015-06-29 | 2019-09-25 | Universiteit Gent | Methods for the site-selective coupling of a first agent to a second agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3838163A (en) * | 1968-11-22 | 1974-09-24 | Hoffmann La Roche | Substituted isoxazole derivatives as steroid intermediates |
-
1974
- 1974-08-08 CH CH1085574A patent/CH621803A5/it not_active IP Right Cessation
-
1975
- 1975-07-29 GB GB31789/75A patent/GB1484655A/en not_active Expired
- 1975-07-30 US US05/600,485 patent/US4000125A/en not_active Expired - Lifetime
- 1975-08-05 DE DE19752534981 patent/DE2534981A1/de not_active Ceased
- 1975-08-07 FR FR7524701A patent/FR2281124A1/fr active Granted
- 1975-08-07 JP JP50095475A patent/JPS5141372A/ja active Pending
- 1975-08-07 AR AR259928A patent/AR217617A1/es active
- 1975-08-07 DK DK358875AA patent/DK139101B/da unknown
- 1975-08-07 SE SE7508908A patent/SE418401B/xx unknown
- 1975-08-07 CA CA233,045A patent/CA1049499A/en not_active Expired
- 1975-08-08 ES ES440110A patent/ES440110A1/es not_active Expired
- 1975-08-08 BE BE159066A patent/BE832271A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA1049499A (en) | 1979-02-27 |
DK139101C (es) | 1979-05-21 |
GB1484655A (en) | 1977-09-01 |
AR217617A1 (es) | 1980-04-15 |
FR2281124A1 (fr) | 1976-03-05 |
ES440110A1 (es) | 1977-02-16 |
SE7508908L (sv) | 1976-02-09 |
DE2534981A1 (de) | 1976-02-19 |
DK358875A (es) | 1976-02-09 |
BE832271A (fr) | 1975-12-01 |
CH621803A5 (es) | 1981-02-27 |
FR2281124B1 (es) | 1980-05-16 |
SE418401B (sv) | 1981-05-25 |
JPS5141372A (es) | 1976-04-07 |
US4000125A (en) | 1976-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK138655B (da) | Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin. | |
DK136718B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner. | |
DK138800B (da) | Analogifremgangsmåde til fremstilling af 4-aminoquinazolinderivater. | |
DK136719B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner. | |
DK136075B (da) | Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater. | |
DK135376B (da) | Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser. | |
DK139101B (da) | Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. | |
DK135711B (da) | Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. | |
DK137835B (da) | Analogifremgangsmåde til fremstilling af thienothiazinderivater. | |
DK139846B (da) | Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider. | |
DK135796B (da) | Fremgangsmåde til fremstilling af alkyl-tert-alkylethere. | |
DK138321B (da) | Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater. | |
DK137389B (da) | Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener. | |
DK135723B (da) | Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner. | |
DK135538B (da) | Fremgangsmåde til fremstilling af 17alfa-ethynyl-(5alfa)-2-androsten-17-beta-ol. | |
DK139682B (da) | Analogifremgangsmåde til fremstilling af eburnameninderivater. | |
DK137043B (da) | Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser. | |
DK132328B (da) | Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on. | |
DK136313B (da) | Analogifremgangsmåde til fremstilling af N-substituerede m-trifluormethylbenzylaminer. | |
DK138227B (da) | Analogifremgangsmåde til fremstilling af substituerede xanthon-2-carboxylsyreforbindelser. | |
DK135167B (da) | Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater. | |
DK137449B (da) | Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid. | |
DK138694B (da) | Fremgangsmåde til fremstilling af phenylphosphonothiodichlorid. | |
DK137646B (da) | Fremgangsmåde til fremstilling af 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxid. | |
DK140670B (da) | Analogifremgangsmåde til fremstilling af ergopeptinderivater. |